Nanopore sequencing identifies differentially methylated genes in the central nervous system in experimental

Wen Si1, Ying Ni1, Qianling Jiang1

  • 1Department of Infectious Diseases and Public Health, Jockey Club College of Veterinary Medicine and Life Sciences, City University of Hong Kong, Kowloon, Hong Kong, SAR 999077, China.

PubMed

Insights

Aberrant DNA methylation in the central nervous system (CNS) may trigger multiple sclerosis (MS). Nanopore sequencing revealed significant promoter methylation changes in an MS animal model, impacting key biological processes.

Area of Science:

  • Neuroimmunology
  • Epigenetics
  • Genomics

Background:

  • Multiple Sclerosis (MS) is a chronic CNS autoimmune disease potentially driven by epigenetic alterations.
  • DNA methylation is a key epigenetic mechanism implicated in MS pathogenesis, but its overall level in the CNS is not well understood.

Purpose of the Study:

  • To investigate genome-wide DNA methylation patterns in the brain of mice with experimental autoimmune encephalomyelitis (EAE), an animal model of MS.
  • To identify differentially methylated genes and their associated biological pathways in EAE.

Main Methods:

  • Direct long-read nanopore DNA sequencing was employed to profile DNA methylation in the EAE mouse brain.
  • Bioinformatic analysis was used to identify hypomethylated and hypermethylated promoters.

Main Results:

  • 163 hypomethylated and 327 hypermethylated promoters were identified in the EAE mouse brain.
  • These methylation changes were associated with critical biological processes including metabolism, immune responses, neural activity, and mitochondrial dynamics.

Conclusions:

  • Nanopore sequencing is a powerful tool for identifying genomic DNA methylation in EAE.
  • The identified methylation alterations provide insights into MS/EAE pathology and suggest potential therapeutic targets.

Related Concept Videos